Facebook
Twitter
Telegram
Report an ErrorNovaBay Pharmaceuticals Cash Flow 2011-2024 | NBY
Annual Cash Flow NovaBay Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-4.13 M | -6.65 M | -9.19 M | -4.72 M | -7.93 M | -5.57 M | -6.27 M | -11.7 M | -18.6 M | -15.1 M | -13 M | -6.53 M | -3.14 M |
Depreciation & Amortization |
51 K | 120 K | 59 K | 51 K | 65 K | 266 K | 95 K | 114 K | 164 K | 232 K | 314 K | 341 K | 425 K |
Accounts Payables |
1.13 M | 1.08 M | 1.04 M | 302 K | 331 K | 551 K | 466 K | 455 K | 2.48 M | 1.86 M | 1.67 M | 455 K | 472 K |
Accounts Receivables |
759 K | 1.97 M | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
2.88 M | 3.44 M | 3.22 M | 608 K | 492 K | 280 K | 504 K | 873 K | 1.34 M | - | 231 K | 23 K | - |
All numbers in USD currency
Quarterly Cash Flow NovaBay Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-1.57 M | - | - | - | -1.19 M | - | -5.44 M | -3.76 M | -2.06 M | - | -4.87 M | -3.41 M | -1.42 M | - | -3.28 M | -1.91 M | -865 K | - | -6.5 M | -5 M | -3.22 M | - | -3.58 M | -1.96 M | -464 K | - | -3.34 M | -3.62 M | -2.01 M | - | -11.4 M | - | -4.93 M | - | - | - | -4.51 M | - | -10.9 M | -8.17 M | -4.42 M | - | -8.29 M | -5.89 M | -45.3 M | - | -3.43 M | -3.69 M | -2.74 M | - | -2.55 M | -3.33 M | 16 K |
Depreciation & Amortization |
12 K | - | 13 K | 13 K | 13 K | - | 29 K | 29 K | 30 K | - | 13 K | 11 K | 9 K | - | 12 K | 14 K | 14 K | - | 17 K | 16 K | 17 K | - | 92 K | 86 K | 41 K | - | 18 K | 18 K | 18 K | - | 31 K | 27 K | 40 K | - | 41 K | 82 K | 41 K | - | 185 K | 141 K | 70 K | - | 240 K | 161 K | 2.65 M | - | 256 K | 174 K | 91 K | - | 321 K | 216 K | 107 K |
Accounts Payables |
1.12 M | 906 K | 947 K | 1.48 M | 1.15 M | 1.08 M | 1.1 M | 930 K | 1.56 M | 1.04 M | 1.35 M | 208 K | 833 K | 302 K | 302 K | 302 K | 302 K | 331 K | 331 K | 331 K | 331 K | 551 K | 551 K | 551 K | 551 K | 466 K | 466 K | 466 K | 466 K | 455 K | 455 K | 455 K | 455 K | 2.48 M | 2.48 M | 2.48 M | 2.18 M | 1.86 M | 1.86 M | 1.86 M | 1.86 M | 1.67 M | 1.67 M | 1.67 M | 1.67 M | 455 K | 455 K | 455 K | 455 K | 472 K | 472 K | 472 K | 472 K |
Accounts Receivables |
734 K | 680 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
663 K | 564 K | 3.49 M | 3.66 M | 3.8 M | 3.44 M | 4.07 M | 3.8 M | 3.44 M | 3.22 M | 969 K | 682 K | 850 K | 608 K | 608 K | 608 K | 608 K | 492 K | 492 K | 492 K | 492 K | 280 K | 280 K | 280 K | 280 K | 504 K | 504 K | 504 K | 504 K | 873 K | 873 K | 873 K | 873 K | 1.34 M | 1.34 M | 1.34 M | - | 521 K | 405 K | 218 K | 155 K | 231 K | 63 K | 231 K | 231 K | 23 K | 23 K | 23 K | 23 K | - | - | - | - |
All numbers in USD currency